Challenges for the prevention of primary and secondary stroke: The importance of lowering blood pressure and total cardiovascular risk

Blood Pressure

Volumn 10, Issue 5-6, 2001, Pages 344-351

  Chalmers, John ^a   Chapman, Neil ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Angiotensin converting enzyme (ACE) inhibitors; Antihypertensive drugs; Blood pressure lowering; Cardiovascular risk; Diuretics; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; PERINDOPRIL; PLACEBO;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; EXERCISE; HEART INFARCTION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SMOKING CESSATION; STROKE; WEIGHT REDUCTION; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; PHYSIOLOGY;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION;

EID: 0035527579     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370501753400647     Document Type: Review

References (39)

1. Epidemiology of stroke
2. Treatment and secondary prevention of stroke: Evidence, costs, and effects on individuals and populations
3. The United Kingdom transient ischemic attack (UK-TIA) aspirin trial: Final results
4. Reducing the global burden of blood-pressure-related cardiovascular disease
5. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
6. Cholesterol, diastolic blood pressure, and stroke: 13000 strokes in 450000 people in 45 prospective cohorts
7. Blood pressure and risk of stroke in patients with cerebrovascular disease
8. Blood pressure, cholesterol, and stroke in eastern Asia
9. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
10. Hypertension awareness, treatment and control in the community: Is the 'rule of halves' still valid?
11. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 patients with previous stroke or transient ischaemic attack
12. Beta blockade after myocardial infarction: Systematic review and meta regression analysis
13. Prevalence of atrial fibrillation and eligibility for anticoagulation in the community
14. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
15. Blood pressure, antihypertensive treatment and stroke risk
16. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure lowering treatments
17. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
18. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
19. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
20. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
21. Hypotensive therapy in stroke survivors
22. Effect of antihypertensive treatment on stroke recurrence
23. Trial of secondary prevention with atenolol after transient ischaemic attack or non-disabling ischaemic stroke
24. Atenolol in secondary prevention after stroke
25. The effects of blood pressure lowering in cerebrovascular disease
26. Effect of antihypertensive treatment in patients having already suffered from stroke: Gathering the evidence
27. Post-stroke antihypertensive treatment study. A preliminary result
28. Characteristics of patients with uncontrolled hypertension in the United States
29. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
30. Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries
31. Barriers to hypertension care and control
32. Continuation of initial antihypertensive therapy after 1 year of therapy
33. Implementation of Guidelines for the management of hypertension
34. Detection, Evaluation and Treatment of High Blood Pressure
35. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension
36. Clinical outcomes in statin treatment trials: A meta-analysis
37. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
38. Prevention of cardiovascular diseases in developing countries: Agenda for action (Statement from a WHO-ISH Meeting in Beijing, October 1999)